- Home
- DVA vs EPAM Comparison
DVA vs EPAM Comparison
Compare DVA & EPAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DVA
- EPAM
- Stock Information
- Founded
- DVA 1994
- EPAM 1993
- Country
- DVA United States
- EPAM United States
- Employees
- DVA N/A
- EPAM N/A
- Industry
- DVA Misc Health and Biotechnology Services
- EPAM EDP Services
- Sector
- DVA Health Care
- EPAM Technology
- Exchange
- DVA Nasdaq
- EPAM Nasdaq
- Market Cap
- DVA 15.2B
- EPAM 15.0B
- IPO Year
- DVA 1995
- EPAM 2012
- Fundamental
- Price
- DVA $147.01
- EPAM $198.90
- Analyst Decision
- DVA Hold
- EPAM Buy
- Analyst Count
- DVA 5
- EPAM 19
- Target Price
- DVA $154.40
- EPAM $268.78
- AVG Volume (30 Days)
- DVA 1.3M
- EPAM 877.2K
- Earning Date
- DVA 05-01-2025
- EPAM 02-20-2025
- Dividend Yield
- DVA N/A
- EPAM N/A
- EPS Growth
- DVA 44.61
- EPAM 11.05
- EPS
- DVA 10.73
- EPAM 7.84
- Revenue
- DVA $12,815,550,000.00
- EPAM $4,727,940,000.00
- Revenue This Year
- DVA $5.76
- EPAM $12.82
- Revenue Next Year
- DVA $3.59
- EPAM $9.43
- P/E Ratio
- DVA $13.70
- EPAM $25.36
- Revenue Growth
- DVA 5.56
- EPAM 0.80
- 52 Week Low
- DVA $125.64
- EPAM $169.43
- 52 Week High
- DVA $179.60
- EPAM $309.48
- Technical
- Relative Strength Index (RSI)
- DVA 41.48
- EPAM 27.23
- Support Level
- DVA $138.64
- EPAM $195.59
- Resistance Level
- DVA $149.06
- EPAM $201.98
- Average True Range (ATR)
- DVA 4.76
- EPAM 9.34
- MACD
- DVA -0.71
- EPAM -3.51
- Stochastic Oscillator
- DVA 42.77
- EPAM 6.22
About DVA DaVita Inc.
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
About EPAM EPAM Systems Inc.
EPAM Systems is a global IT services firm that offers platform engineering, software development, and consulting services. EPAM's largest market is North America, which represents approximately 60% of revenue. Offerings span assisting companies with new technologies, such as artificial intelligence, virtual reality, and robotics.